These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25773970)

  • 1. Albuminated PLGA nanoparticles containing bevacizumab intended for ocular neovascularization treatment.
    Varshochian R; Riazi-Esfahani M; Jeddi-Tehrani M; Mahmoudi AR; Aghazadeh S; Mahbod M; Movassat M; Atyabi F; Sabzevari A; Dinarvand R
    J Biomed Mater Res A; 2015 Oct; 103(10):3148-56. PubMed ID: 25773970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protective effect of albumin on bevacizumab activity and stability in PLGA nanoparticles intended for retinal and choroidal neovascularization treatments.
    Varshochian R; Jeddi-Tehrani M; Mahmoudi AR; Khoshayand MR; Atyabi F; Sabzevari A; Esfahani MR; Dinarvand R
    Eur J Pharm Sci; 2013 Nov; 50(3-4):341-52. PubMed ID: 23933615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory efficacy of intravitreal dexamethasone acetate-loaded PLGA nanoparticles on choroidal neovascularization in a laser-induced rat model.
    Xu J; Wang Y; Li Y; Yang X; Zhang P; Hou H; Shi Y; Song C
    J Ocul Pharmacol Ther; 2007 Dec; 23(6):527-40. PubMed ID: 18001232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation.
    Pandit J; Sultana Y; Aqil M
    Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1397-1407. PubMed ID: 27855494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An injectable thermosensitive polymeric hydrogel for sustained release of Avastin® to treat posterior segment disease.
    Xie B; Jin L; Luo Z; Yu J; Shi S; Zhang Z; Shen M; Chen H; Li X; Song Z
    Int J Pharm; 2015 Jul; 490(1-2):375-83. PubMed ID: 26027491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
    Duvvuri S; Janoria KG; Pal D; Mitra AK
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal administration of dexamethasone-loaded PLGA-TPGS nanoparticles for the treatment of posterior segment diseases.
    Yang C; Jiang L; Bu S; Zhang L; Xie X; Zeng Q; Zhu D; Zheng Y
    J Biomed Nanotechnol; 2013 Sep; 9(9):1617-23. PubMed ID: 23980509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan coated nanoparticles for efficient delivery of bevacizumab in the posterior ocular tissues via subconjunctival administration.
    Pandit J; Sultana Y; Aqil M
    Carbohydr Polym; 2021 Sep; 267():118217. PubMed ID: 34119171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymeric Propranolol Nanoparticles for Intraocular Delivery: Formulation, Characterization, and Vitreous Pharmacokinetics.
    Chaharband F; Varshochian R; Dinarvand R; Sabbaghi H; Rezaei Kanavi M; Daftarian N; Nourinia R
    J Ophthalmic Vis Res; 2024; 19(1):41-50. PubMed ID: 38638633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivesicular liposomes for sustained release of bevacizumab in treating laser-induced choroidal neovascularization.
    Mu H; Wang Y; Chu Y; Jiang Y; Hua H; Chu L; Wang K; Wang A; Liu W; Li Y; Fu F; Sun K
    Drug Deliv; 2018 Nov; 25(1):1372-1383. PubMed ID: 29869520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting nanoparticle-loaded bilayer microneedles for protein delivery to the posterior segment of the eye.
    Wu Y; Vora LK; Wang Y; Adrianto MF; Tekko IA; Waite D; Donnelly RF; Thakur RRS
    Eur J Pharm Biopharm; 2021 Aug; 165():306-318. PubMed ID: 34048879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depot injectable biodegradable nanoparticles loaded with recombinant human bone morphogenetic protein-2: preparation, characterization, and in vivo evaluation.
    Hassan AH; Hosny KM; Murshid ZA; Alhadlaq A; Alyamani A; Naguib G
    Drug Des Devel Ther; 2015; 9():3599-606. PubMed ID: 26203226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular implant containing bevacizumab-loaded chitosan nanoparticles intended for choroidal neovascularization treatment.
    Badiee P; Varshochian R; Rafiee-Tehrani M; Abedin Dorkoosh F; Khoshayand MR; Dinarvand R
    J Biomed Mater Res A; 2018 Aug; 106(8):2261-2271. PubMed ID: 29637733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle-integrin antagonist C16Y peptide treatment of choroidal neovascularization in rats.
    Kim H; Csaky KG
    J Control Release; 2010 Mar; 142(2):286-93. PubMed ID: 19895863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new paradigm for antiangiogenic therapy through controlled release of bevacizumab from PLGA nanoparticles.
    Sousa F; Cruz A; Fonte P; Pinto IM; Neves-Petersen MT; Sarmento B
    Sci Rep; 2017 Jun; 7(1):3736. PubMed ID: 28623267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
    Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric nanoparticles augment the ocular hypotensive effect of melatonin in rabbits.
    Musumeci T; Bucolo C; Carbone C; Pignatello R; Drago F; Puglisi G
    Int J Pharm; 2013 Jan; 440(2):135-40. PubMed ID: 23078856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled release bevacizumab in thermoresponsive hydrogel found to inhibit angiogenesis.
    Hu CC; Chaw JR; Chen CF; Liu HW
    Biomed Mater Eng; 2014; 24(6):1941-50. PubMed ID: 25226890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
    Chan JM; Zhang L; Yuet KP; Liao G; Rhee JW; Langer R; Farokhzad OC
    Biomaterials; 2009 Mar; 30(8):1627-34. PubMed ID: 19111339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.